Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Epoca
AddedFeb 17, 2024
UpdatedJun 18, 2026
Epoca

Epoca

Series A

Epoca: A med-tech startup providing home-based care for acute and chronic patients through connected devices.

HQ
San Francisco, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Epoca is a medical technology startup focused on transforming patient care by enabling home-based treatment for individuals with acute or chronic illnesses. Founded with a mission to reduce hospital visits and improve patient outcomes, Epoca offers connected gadgets, a data analysis platform, and a medical and paramedical team for remote monitoring and coordination. Their vision is to create a seamless healthcare experience that prioritizes patient comfort and accessibility, targeting both emergency room patients and those with ongoing health conditions.

Notable figures associated with Epoca include industry experts in medical technology and healthcare innovation. The company has garnered attention from investors interested in the burgeoning field of telehealth and remote patient monitoring. Key achievements include successful pilot programs demonstrating reduced hospital readmissions and improved patient satisfaction. Epoca's innovative approach has made a significant impact on the healthcare industry by providing a viable alternative to traditional hospital-based care, enhancing the quality of life for many patients.

Epoca - Similar Companies

Medically Home logo

Medically Home

Locus Health logo

Locus Health

locushealth.com

Epimedica logo

Epimedica

HealthSnap logo

HealthSnap

Tomorrow Health logo

Tomorrow Health

tomorrowhealth.com

MedArrive logo

MedArrive

medarrive.com

Anthem-Epoch logo

Anthem-Epoch

Epic Health logo

Epic Health

Float Health logo

Float Health

float.health

EpiWatch logo

EpiWatch

epiwatch.com

Accompany Health logo

Accompany Health

Empo Health logo

Empo Health

empohealth.com

DailyDoctor logo

DailyDoctor

mydailydoctor.com

Inbound Health logo

Inbound Health

inboundhealth.com

Cadence logo

Cadence

cadence.care

Epoca - Quick Facts

Who are Epoca's competitors?

Companies similar to Epoca include Medically Home, Locus Health, Epimedica and HealthSnap.

When was Epoca founded?

Epoca was founded in 2019.

Where is Epoca's headquarters located?

Epoca's headquarters is located in San Francisco, CA, US.

When was Epoca's last funding round?

Epoca's most recent funding round was for $10M (USD) in September 2023.

How much has Epoca raised to-date?

As of Sep 21, 2023, Epoca has raised a total of $10M (USD).

How many employees does Epoca have?

Epoca has 37 employees as of Feb 4, 2024.

Epoca - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
  • Telemedicine
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Home Healthcare
Tags
  • Healthtech
NAICS
  • 459500Used Merchandise Retailers
  • 459510Used Merchandise Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 5930Used Merchandise Stores
  • 5932Used Merchandise Stores
  • 5900Miscellaneous Retail
ISIC
  • 4774Retail sale of second-hand goods
Show 1 more industry code
NAICS
  • 440000Retail Trade